Related Experiment Videos

Bacterial endocarditis treated with intramuscular teicoplanin

S Chauhan1, S D'Cruz, A Sachdev

  • 1Department of Medicine, Government Medical College and Hospital, Chandigarh, Union Territory, India. drsc88@rediffmail.com

Singapore Medical Journal
|August 31, 2007
PubMed

Insights

Right-sided endocarditis in parenteral drug users requires long antibiotic courses. Intramuscular teicoplanin was used successfully when intravenous options were unavailable.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pharmacology

Background:

  • Parenteral drug abuse is a significant risk factor for right-sided endocarditis, often caused by Staphylococcus aureus.
  • Standard treatment involves prolonged intravenous antibiotics, typically cloxacillin and aminoglycosides, or vancomycin for specific cases.
  • Teicoplanin, a glycopeptide antibiotic, has shown limited success when administered intravenously for this condition.

Observation:

  • A case study of a 37-year-old parenteral drug user with right-sided endocarditis is presented.
  • The patient required treatment with teicoplanin due to a lack of alternative therapeutic options.
  • Intravenous administration was not feasible, necessitating intramuscular delivery of teicoplanin.

Findings:

  • Intramuscular administration of teicoplanin was successfully employed in this patient with right-sided endocarditis.
  • This route of administration was chosen due to the absence of other viable treatment alternatives.
  • The outcome suggests intramuscular teicoplanin may be a viable option in select, challenging cases.

Implications:

  • This case highlights the potential utility of intramuscular teicoplanin for right-sided endocarditis when intravenous therapy is not possible.
  • It expands treatment considerations for Staphylococcus aureus endocarditis in parenteral drug users.
  • Further research into the efficacy and safety of intramuscular glycopeptide administration in endocarditis is warranted.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...